Organon (OGN) EV to FCF (2021 - 2026)
Organon (OGN) posted EV to FCF of 37.29 for Q2 2026, up 1433.05% on a QoQ basis from 2.43 in Q1 2026, and up 251.98% year-over-year from 10.59 in Q2 2025.
Analysis
Organon (OGN) EV to FCF (2021 - 2026) Analysis & Trends
Organon has reported EV to FCF for 6 years, with the latest figure at 37.29 in Q2 2026.
- On a quarterly basis, EV to FCF rose 251.98% year-over-year to 37.29 in Q2 2026; TTM through Jun 2026 was 4.27, a 46.69% increase from a year earlier, with the FY2025 full-year figure at 2.4, down 41.59% from the prior year.
- EV to FCF was 37.29 for Q2 2026 at Organon, up from 2.43 in the prior quarter.
- The five-year high for EV to FCF was 141.16 in Q1 2024, with the low at 113.46 in Q2 2023.
- Average EV to FCF over 5 years is 31.86, with a median of 20.17 recorded in 2022.
- The sharpest annual moves came in 2022 and 2023: EV to FCF surged 321.7% in 2022, then slumped 249.62% in 2023.
- Over 5 years, EV to FCF stood at 31.37 in 2022, then sank by 70.08% to 9.38 in 2023, then dropped by 0.04% to 9.38 in 2024, then jumped by 43.53% to 13.46 in 2025, then surged by 176.96% to 37.29 in 2026.
- The last three EV to FCF figures came in at 37.29 (Q2 2026), 2.43 (Q1 2026), and 13.46 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn |
| 10 | Organon | 3.58 Bn | 2.45 Bn | 847.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 37.29 |
| Mar 31, 2026 | 2.43 |
| Dec 31, 2025 | 13.46 |
| Sep 30, 2025 | 9.65 |
| Jun 30, 2025 | 10.59 |
| Mar 31, 2025 | 76.60 |
| Dec 31, 2024 | 9.38 |
| Sep 30, 2024 | 42.06 |
| Jun 30, 2024 | 15.42 |
| Mar 31, 2024 | 141.16 |
| Dec 31, 2023 | 9.38 |
| Sep 30, 2023 | 19.53 |
| Jun 30, 2023 | -113.46 |
| Mar 31, 2023 | 81.25 |
| Dec 31, 2022 | 31.37 |
| Sep 30, 2022 | 20.81 |
| Jun 30, 2022 | 75.83 |
| Mar 31, 2022 | 90.73 |
| Dec 31, 2021 | -582.19 |
| Sep 30, 2021 | 22.01 |